Startups
SQ Innovation is a privately-held Swiss biopharmaceutical company located in Zug, Switzerland, Burlington, MA, and Rotterdam, The Netherlands,. The company was established to develop and commercialize innovative cost-effective therapies for subcutaneous delivery of pharmaceutical products where and when needed. Its first product was designed specifically for the treatment of fluid overload due to worsening heart failure. The product called Lasix ONYU was approved by the US FDA on October 7 2025. The innovative combination product is based on a novel high-concentration formulation and uses a cost-effective two-component device design. The device was designed with the patient, provider, payor and environment in mind. The Infusor uses a reusable motorized component and a disposable component. The company's products are subject to regulatory review and approval.
Overview
Location
Switzerland
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 7, 2026 | Swiss medtechs hit milestones in cardiovascular care | Founded in 2016 and headquartered in Baar, CorFlow Therapeutics develops the Controlled Flow Infusion (CoFI) System for the diagnosis and treatment of microvascular obstruction (MVO), a complication that occurs in more than half of heart a... |
| Feb 12, 2026 | From trials to market: medtechs advance clinical programs | Founded in the Canton of Vaud in 2015, Aspivix developed carevix, a soft-suction cervical device designed as a modern, gentler alternative to the cervical tenaculum. The company has announced the publication of a multicentre post-marketing... |
| Oct 13, 2025 | Following FDA approval, SQ Innovation closes Series B financing | Lasix ONYU was developed to enable subcutaneous infusion of furosemide outside the healthcare setting for selected patients, as prescribed by a clinician without the need for a healthcare professional to administer the drug. Lasix ONYU con... |
Reviews 0
FAQ about SQ Innovation
What has the press written about SQ Innovation?
Parsers VC has collected 4 articles mentioning SQ Innovation, among them “Swiss medtechs hit milestones in cardiovascular care” (May 7, 2026) and “From trials to market: medtechs advance clinical programs” (Feb 12, 2026).
Is SQ Innovation still active?
Yes, SQ Innovation is active; its latest activity on Parsers VC dates from Oct 20, 2026.